메뉴 건너뛰기




Volumn 101, Issue 2, 2009, Pages 357-362

Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array

Author keywords

ATM; Efficacy; ERCC5; Oxaliplatin; SNP array; Toxicity

Indexed keywords

ATM PROTEIN; CAPECITABINE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 5; IRINOTECAN; OXALIPLATIN; PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CELL CYCLE PROTEIN; DEOXYCYTIDINE; DNA; DNA BINDING PROTEIN; DNA EXCISION REPAIR PROTEIN ERCC 5; DNA EXCISION REPAIR PROTEIN ERCC-5; DRUG DERIVATIVE; ENDONUCLEASE; FLUOROURACIL; NUCLEAR PROTEIN; PLATINUM COMPLEX; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

EID: 67650627436     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605134     Document Type: Article
Times cited : (33)

References (31)
  • 1
    • 33646870784 scopus 로고    scopus 로고
    • Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer
    • Booton R, Ward T, Heighway J, Taylor P, Power F, Ashcroft L, Morris J, Thatcher N (2006) Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer. Cancer 106: 2421-2427
    • (2006) Cancer , vol.106 , pp. 2421-2427
    • Booton, R.1    Ward, T.2    Heighway, J.3    Taylor, P.4    Power, F.5    Ashcroft, L.6    Morris, J.7    Thatcher, N.8
  • 2
    • 0037426052 scopus 로고    scopus 로고
    • Problems of reporting genetic associations with complex outcomes
    • Colhoun HM, McKeigue PM, Davey SG (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361: 865-872
    • (2003) Lancet , vol.361 , pp. 865-872
    • Colhoun, H.M.1    McKeigue, P.M.2    Davey, S.G.3
  • 3
    • 33748754078 scopus 로고    scopus 로고
    • The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment
    • Colton SL, Xu XS, Wang YA, Wang G (2006) The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment. J Biol Chem 281: 27117-27125
    • (2006) J Biol Chem , vol.281 , pp. 27117-27125
    • Colton, S.L.1    Xu, X.S.2    Wang, Y.A.3    Wang, G.4
  • 6
    • 4344567395 scopus 로고    scopus 로고
    • XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy
    • Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 22: 2594-2601
    • (2004) J Clin Oncol , vol.22 , pp. 2594-2601
    • Gurubhagavatula, S.1    Liu, G.2    Park, S.3    Zhou, W.4    Su, L.5    Wain, J.C.6    Lynch, T.J.7    Neuberg, D.S.8    Christiani, D.C.9
  • 8
    • 34548726841 scopus 로고    scopus 로고
    • Silent SNPs: Impact on gene function and phenotype
    • Komar AA (2007) Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 8: 1075-1080
    • (2007) Pharmacogenomics , vol.8 , pp. 1075-1080
    • Komar, A.A.1
  • 9
    • 33749598266 scopus 로고    scopus 로고
    • Randomised study of sequential vs combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study
    • Koopman M, Antonini NF, Douma J, Wals J, Honkoop AH, Erdkamp FL, de Jong RS, Rodenburg CJ, Vreugdenhil G, Akkermans-Vogelaar JM, Punt CJ (2006) Randomised study of sequential vs combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study. Ann Oncol 17: 1523-1528
    • (2006) Ann Oncol , vol.17 , pp. 1523-1528
    • Koopman, M.1    Antonini, N.F.2    Douma, J.3    Wals, J.4    Honkoop, A.H.5    Erdkamp, F.L.6    de Jong, R.S.7    Rodenburg, C.J.8    Vreugdenhil, G.9    Akkermans-Vogelaar, J.M.10    Punt, C.J.11
  • 11
    • 17444422174 scopus 로고    scopus 로고
    • Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy
    • Kweekel DM, Gelderblom H, Guchelaar HJ (2005) Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy. Cancer Treat Rev 31: 90-105
    • (2005) Cancer Treat Rev , vol.31 , pp. 90-105
    • Kweekel, D.M.1    Gelderblom, H.2    Guchelaar, H.J.3
  • 12
    • 48249145381 scopus 로고    scopus 로고
    • UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: A Dutch Colorectal Cancer Group study
    • Kweekel DM, Gelderblom H, Van der Straaten T, Antonini NF, Punt CJ, Guchelaar HJ (2008) UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study. Br J Cancer 99: 275-282
    • (2008) Br J Cancer , vol.99 , pp. 275-282
    • Kweekel, D.M.1    Gelderblom, H.2    Van der Straaten, T.3    Antonini, N.F.4    Punt, C.J.5    Guchelaar, H.J.6
  • 13
    • 37649009185 scopus 로고    scopus 로고
    • Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: Relationships with treatment outcome
    • Le Morvan V, Smith D, Laurand A, Brouste V, Bellott R, Soubeyran I, Mathoulin-Pelissier S, Robert J (2007) Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome. Pharmacogenomics 8: 1693-1703
    • (2007) Pharmacogenomics , vol.8 , pp. 1693-1703
    • Le Morvan, V.1    Smith, D.2    Laurand, A.3    Brouste, V.4    Bellott, R.5    Soubeyran, I.6    Mathoulin-Pelissier, S.7    Robert, J.8
  • 14
    • 33645814832 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer
    • Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, Abbruzzese JL (2006) Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 24: 1720-1728
    • (2006) J Clin Oncol , vol.24 , pp. 1720-1728
    • Li, D.1    Frazier, M.2    Evans, D.B.3    Hess, K.R.4    Crane, C.H.5    Jiao, L.6    Abbruzzese, J.L.7
  • 15
    • 39049168449 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/ fluoropyrimidine
    • Monzo M, Moreno I, Navarro A, Ibeas R, Artells R, Gel B, Martinez F, Moreno J, Hernandez R, Navarro-Vigo M (2007) Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/ fluoropyrimidine. Oncology 72: 364-370
    • (2007) Oncology , vol.72 , pp. 364-370
    • Monzo, M.1    Moreno, I.2    Navarro, A.3    Ibeas, R.4    Artells, R.5    Gel, B.6    Martinez, F.7    Moreno, J.8    Hernandez, R.9    Navarro-Vigo, M.10
  • 16
    • 42249105871 scopus 로고    scopus 로고
    • Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer
    • Okazaki T, Jiao L, Chang P, Evans DB, Abbruzzese JL, Li D (2008) Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. Clin Cancer Res 14: 2042-2048
    • (2008) Clin Cancer Res , vol.14 , pp. 2042-2048
    • Okazaki, T.1    Jiao, L.2    Chang, P.3    Evans, D.B.4    Abbruzzese, J.L.5    Li, D.6
  • 17
    • 0035893755 scopus 로고    scopus 로고
    • A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer
    • Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ (2001) A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 61: 8654-8658
    • (2001) Cancer Res , vol.61 , pp. 8654-8658
    • Park, D.J.1    Stoehlmacher, J.2    Zhang, W.3    Tsao-Wei, D.D.4    Groshen, S.5    Lenz, H.J.6
  • 19
    • 6944234851 scopus 로고    scopus 로고
    • New options and old dilemmas in the treatment of patients with advanced colorectal cancer
    • Punt CJ (2004) New options and old dilemmas in the treatment of patients with advanced colorectal cancer. Ann Oncol 15: 1453-1459
    • (2004) Ann Oncol , vol.15 , pp. 1453-1459
    • Punt, C.J.1
  • 21
    • 34748848707 scopus 로고    scopus 로고
    • Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients
    • Saldivar JS, Lu KH, Liang D, Gu J, Huang M, Vlastos AT, Follen M, Wu X (2007) Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients. Gynecol Oncol 107: S223-S229
    • (2007) Gynecol Oncol , vol.107
    • Saldivar, J.S.1    Lu, K.H.2    Liang, D.3    Gu, J.4    Huang, M.5    Vlastos, A.T.6    Follen, M.7    Wu, X.8
  • 23
    • 3843130823 scopus 로고    scopus 로고
    • A multivariate analysis of genomic polymorphisms: Prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
    • Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ (2004) A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 91: 344-354
    • (2004) Br J Cancer , vol.91 , pp. 344-354
    • Stoehlmacher, J.1    Park, D.J.2    Zhang, W.3    Yang, D.4    Groshen, S.5    Zahedy, S.6    Lenz, H.J.7
  • 24
    • 34247172071 scopus 로고    scopus 로고
    • Genetic polymorphisms and treatment response in advanced non-small cell lung cancer
    • Su D, Ma S, Liu P, Jiang Z, Lv W, Zhang Y, Deng Q, Smith S, Yu H (2007) Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer 56: 281-288
    • (2007) Lung Cancer , vol.56 , pp. 281-288
    • Su, D.1    Ma, S.2    Liu, P.3    Jiang, Z.4    Lv, W.5    Zhang, Y.6    Deng, Q.7    Smith, S.8    Yu, H.9
  • 26
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van GM, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3    Wanders, J.4    Kaplan, R.S.5    Rubinstein, L.6    Verweij, J.7    Van, G.M.8    van Oosterom, A.T.9    Christian, M.C.10    Gwyther, S.G.11
  • 29
    • 24344479165 scopus 로고    scopus 로고
    • ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer
    • Viguier J, Boige V, Miquel C, Pocard M, Giraudeau B, Sabourin JC, Ducreux M, Sarasin A, Praz F (2005) ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer. Clin Cancer Res 11: 6212-6217
    • (2005) Clin Cancer Res , vol.11 , pp. 6212-6217
    • Viguier, J.1    Boige, V.2    Miquel, C.3    Pocard, M.4    Giraudeau, B.5    Sabourin, J.C.6    Ducreux, M.7    Sarasin, A.8    Praz, F.9
  • 30
    • 36249029788 scopus 로고    scopus 로고
    • Pathway-based approaches for analysis of genomewide association studies
    • Wang K, Li M, Bucan M (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81: 1278-1283
    • (2007) Am J Hum Genet , vol.81 , pp. 1278-1283
    • Wang, K.1    Li, M.2    Bucan, M.3
  • 31
    • 4143051317 scopus 로고    scopus 로고
    • Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    • Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC (2004) Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 10: 4939-4943
    • (2004) Clin Cancer Res , vol.10 , pp. 4939-4943
    • Zhou, W.1    Gurubhagavatula, S.2    Liu, G.3    Park, S.4    Neuberg, D.S.5    Wain, J.C.6    Lynch, T.J.7    Su, L.8    Christiani, D.C.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.